NeuroTherapia to Present Phase 2a Alzheimer's Disease Clinical Data at the AAIC 2026 Conference in London, UK
Encouraging Data Demonstrating Target Engagement will be Presented in a Poster on Monday July 13ᵗʰ CLEVELAND, July 13, 2026 /PRNewswire/ -- NeuroTherapia, Inc., a clinical-stage company focused on developing oral therapies for neurodegenerative diseases, will be presenting data from its...
Encouraging Data Demonstrating Target Engagement will be Presented in a Poster on Monday July 13ᵗʰ CLEVELAND, July 13, 2026 /PRNewswire/ -- NeuroTherapia, Inc., a clinical-stage company focused on developing oral therapies for neurodegenerative diseases, will be presenting data from its...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.